Literature DB >> 10566599

Polymorphism in the promoter region of tumor necrosis factor-alpha gene is associated with severe meliodosis.

S Nuntayanuwat1, T Dharakul, W Chaowagul, S Songsivilai.   

Abstract

Melioidosis is an important infectious disease endemic in Southeast Asia and the Northern territories of Australia. Septicemic melioidosis, is the leading cause of fatality from community acquired septicemia in northeastern part of Thailand where death often occurs within a few days after hospitalization. The present study was carried out to investigate the polymorphisms of the position -308 promoter region of the TNF-alpha gene, as well as of the intron 1 of the TNF-beta gene in patients with melioidosis compared with normal uninfected controls in the same endemic area. The gene frequency of TNF2 allele was significantly higher in melioidosis patients compared with control subjects (p = 0.0097, relative risk 2.32). The increase in TNF2 allele in melioidosis patients was found in both heterozygous and homozygous forms. In addition, the increase in TNF2 allele was most apparent in patients who had fatal outcome from septicemic melioidosis (p = 0.017), but was also observed with lesser degree in other groups of melioidosis patients. However, no difference in the frequency of TNF-beta polymorphism the melioidosis patients was observed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566599     DOI: 10.1016/s0198-8859(99)00073-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  10 in total

1.  Genetic control of weight loss during pneumonic Burkholderia pseudomallei infection.

Authors:  Felicia D Emery; Jyothi Parvathareddy; Ashutosh K Pandey; Yan Cui; Robert W Williams; Mark A Miller
Journal:  Pathog Dis       Date:  2014-04-22       Impact factor: 3.166

Review 2.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

Review 4.  Melioidosis.

Authors:  W Joost Wiersinga; Harjeet S Virk; Alfredo G Torres; Bart J Currie; Sharon J Peacock; David A B Dance; Direk Limmathurotsakul
Journal:  Nat Rev Dis Primers       Date:  2018-02-01       Impact factor: 52.329

5.  Toll-like receptor 4 region genetic variants are associated with susceptibility to melioidosis.

Authors:  T E West; W Chierakul; N Chantratita; D Limmathurotsakul; V Wuthiekanun; M J Emond; T R Hawn; S J Peacock; S J Skerrett
Journal:  Genes Immun       Date:  2011-07-21       Impact factor: 2.676

6.  In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei.

Authors:  R Perumal Samy; A Pachiappan; P Gopalakrishnakone; Maung M Thwin; Yap E Hian; Vincent T K Chow; Ho Bow; Joseph T Weng
Journal:  BMC Infect Dis       Date:  2006-06-20       Impact factor: 3.090

7.  Association between the Lymphotoxin-α A252g Gene Polymorphism and the Risk of Sepsis and Mortality: A Meta-Analysis.

Authors:  Shujin Guo; Qiunan Zuo; Xiaohui Li; Ye He; Yutian Zhou
Journal:  Biomed Res Int       Date:  2020-08-20       Impact factor: 3.411

8.  Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease.

Authors:  Mehmet Küçükaycan; Michiel Van Krugten; Herman-Jan Pennings; Tom W J Huizinga; Wim A Buurman; Mieke A Dentener; Emiel F M Wouters
Journal:  Respir Res       Date:  2002-11-29

9.  The effects of tumor necrosis factor-α (TNF-α) rs1800629 and rs361525 polymorphisms on sepsis risk.

Authors:  Yixin Zhang; Xiaoteng Cui; Li Ning; Dianjun Wei
Journal:  Oncotarget       Date:  2017-11-30

10.  Tumor necrosis factor-α -308 G/A polymorphism and risk of sepsis, septic shock, and mortality: an updated meta-analysis.

Authors:  Hao Wang; Shujin Guo; Chun Wan; Ting Yang; Ni Zeng; Yanqiu Wu; Lei Chen; Yongchun Shen; Fuqiang Wen
Journal:  Oncotarget       Date:  2017-09-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.